Loading organizations...
Senrigan Capital manages a hedge fund specializing in event-driven investment strategies across Asia. The firm focuses on identifying and profiting from corporate actions such as mergers, tender offers, joint ventures, and special situations, rather than taking directional market risk. It employs a rigorous analytical approach, including extensive historical research on deal behavior during market disruptions, to uncover mispricings and anomalies in complex corporate events within target markets.
Nick Taylor, a seasoned specialist in event-driven strategies with a background as a philosophy lecturer and extensive experience in Asian finance, founded Senrigan Capital in early 2009. His insight stemmed from recognizing a significant opportunity for non-directional, event-driven investing in Asia, particularly during a period when traditional market-correlated strategies faced challenges, leading him to launch a firm focused on exploiting specific corporate catalysts.
The firm serves institutional investors seeking exposure to Asian markets without inherent market correlation, attracting clients like fund-of-funds firms. Senrigan Capital's vision involves continuously leveraging its deep regional expertise and analytical capabilities to navigate the unique cultural and legal landscapes of countries like mainland China, Japan, and Australia. The firm aims to remain at the forefront of sophisticated event-driven investing, capitalizing on evolving corporate activity across the continent.
Senrigan Capital has 1 tracked investment across 1 company. The latest tracked deal is $25.0M Other Equity in REVA Medical in November 2014.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Nov 21, 2014 | REVA Medical | $25.0M Other Equity | Goldman Sachs, Senrigan Capital | — |